TU-2100, also kn own as Azasal-2100 and Azeloyl diethyl salicylate, is a drug candidate potentially for the treatment of acne rosacea, psoriasis and hair growth disorders. ( 10/6/2016) References: Sintov AC, Behar-Canetti C, Friedman Y, Tamarkin D. Percutaneous penetration and skin metabolism of ethylsalicylate-containing agent, TU-2100: in-vitro and in-vivo evaluation in guinea pigs. J Control Release. 2002 Feb 19;79(1-3):113-22. PubMed PMID: 11853923.

纯度：≥98%

CAS：207972-39-2